Health Current Affairs

Enter Your Email Address To Subscribe Current Affairs Daily Digest, Daily Quiz and other updates on Current Affairs:

Nanomedicine for Blood Cancer developed

The Kochi-based Amrita Centre for Nanosciences and Molecular Medicine has developed a nano-medicine for drug-resistant blood cancer. This invention expected to significantly improve the treatment of drug-resistant Chronic Myelogenous Leukemia (CML), when used in combination with Imatinib, the standard drug for the disease.

In another major invention, the institute has developed a mechanism that can efficaciously prevent recurrence of glioma or brain tumour. This disease affects about 4 out of every 100000 people in India.

What is Chronic Myelogenous Leukemia?

Chronic Myelogenous Leukemia is a form of blood cancer which affects around 2 out of every 100000 Indians annually.


Indian-origin scientist discovers universal flu vaccine

Screenshot_5A team of researchers led by Professor Ajit Lalvani from the National Heart and Lung Institute at Imperial College London have discovered a new way of combating viral flu infections. He has developed a roadmap to develop universal flu vaccine.

What is the approach to develop universal flu vaccine?

Scientists investigated why some people resist severe illnesses of influenza virus. They found that the people who evade severe flu illnesses had more CD8 T cells in their blood at the start of the pandemic. CD8T cells are a type of virus killing immune cell. They concluded that a vaccine which can stimulate the body to produce more of these cells could be effective at preventing flu viruses, including new strains that infect humans from birds and pigs.

How CD8T cells function differently than normal antibodies?

The specific quality of CD8T cells which renders it the potential to kill different strains of flu viruses is that it attacks the core of the virus unlike normal antibodies which target the surface of a virus. The flu virus rapidly changes its surface which makes older vaccine less effective. However, CD8T cells attack the core of the virus which remains the same. So, even if the virus changes its outer structure it would not affect the potential of CD8T cells to target them.


Dextrose Gel can help treat Hypoglycaemia in Premature Babies

As per scientists from the University of Auckland, New Zealand the dose of sugar in the form of gel can help prevent premature babies from the risk of brain damage due to Hypoglycaemia. This is named as Dextrose gel treatment. 

During this treatment, the sugar gel should be rubbed in the inside of cheeks and it has been found as the effective and cheapest possible way. Around 10% of premature babies face the risk of low blood sugar level, which eventually affects them. If left untreated, it can cause permanent damage.

As per researchers, dextrose treatment this should become the first-line treatment. The cost of Dextrose gel treatment is merely 1 Pound per baby and is also simple to administer in comparison with the glucose through the drip.

However, the treatment has to go through further research for implementation of the treatment.

What is Hypoglycemia?

A medical emergency condition in which body has abnormally low levels of blood sugar (glucose) is called as hypoglycemia. Glucose is the body’s main energy source. Hypoglycemia is not a disease in itself; it is a sign of a health problem.